187 related articles for article (PubMed ID: 26995301)
1. Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: A systematic review and meta-analysis.
Leporini C; Pisano A; Russo E; D Arrigo G; de Sarro G; Coppolino G; Bolignano D
Pharmacol Res; 2016 May; 107():315-332. PubMed ID: 26995301
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
Liu D; Wang LN; Li HX; Huang P; Qu LB; Chen FY
J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update.
Chen YM; Chiang WC; Lin SL; Tsai TJ
J Biomed Sci; 2017 Nov; 24(1):84. PubMed ID: 29132351
[TBL] [Abstract][Full Text] [Related]
4. Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis.
Jiang X; Zhou S; Yao J; Kong X; Cui M
J Nephrol; 2016 Oct; 29(5):653-62. PubMed ID: 26510426
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Bolignano D; D'Arrigo G; Pisano A; Coppolino G
PLoS One; 2015; 10(8):e0134104. PubMed ID: 26237421
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline, progression of chronic kidney disease (CKD) and cardiovascular mortality: long-term follow-up of a randomized clinical trial.
de Morales AM; Goicoechea M; Verde E; Carbayo J; Barbieri D; Delgado A; Verdalles U; de Jose AP; Luño J
J Nephrol; 2019 Aug; 32(4):581-587. PubMed ID: 30949987
[TBL] [Abstract][Full Text] [Related]
7. The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis.
Zhang Z; Wu P; Zhang J; Wang S; Zhang G
Pharmacol Res; 2016 Mar; 105():74-83. PubMed ID: 26776964
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease.
Chen PM; Lai TS; Chen PY; Lai CF; Wu V; Chiang WC; Chen YM; Wu KD; Tsai TJ
J Formos Med Assoc; 2014 Apr; 113(4):219-26. PubMed ID: 24512756
[TBL] [Abstract][Full Text] [Related]
9. Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
Renke M; Tylicki L; Rutkowski P; Knap N; Zietkiewicz M; Neuwelt A; Aleksandrowicz E; Łysiak-Szydłowska W; Woźniak M; Rutkowski B
Acta Biochim Pol; 2010; 57(1):119-23. PubMed ID: 20309434
[TBL] [Abstract][Full Text] [Related]
10. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks.
Murkamilov IT; Aitbaev KA; Fomin VV; Murkamilova ZA; Bayzhigitova AA
Ter Arkh; 2019 Mar; 91(1):95-100. PubMed ID: 31090379
[TBL] [Abstract][Full Text] [Related]
12. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.
Ghorbani A; Omidvar B; Beladi-Mousavi SS; Lak E; Vaziri S
Nefrologia; 2012; 32(6):790-6. PubMed ID: 23169362
[TBL] [Abstract][Full Text] [Related]
13. The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
McCormick BB; Sydor A; Akbari A; Fergusson D; Doucette S; Knoll G
Am J Kidney Dis; 2008 Sep; 52(3):454-63. PubMed ID: 18433957
[TBL] [Abstract][Full Text] [Related]
14. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
Chen YM; Lin SL; Chiang WC; Wu KD; Tsai TJ
Kidney Int; 2006 Apr; 69(8):1410-5. PubMed ID: 16541021
[TBL] [Abstract][Full Text] [Related]
16. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
[TBL] [Abstract][Full Text] [Related]
17. Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.
Kuo KL; Hung SC; Liu JS; Chang YK; Hsu CC; Tarng DC
Sci Rep; 2015 Nov; 5():17150. PubMed ID: 26612282
[TBL] [Abstract][Full Text] [Related]
18. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial.
Silveira MAD; Teles F; Berretta AA; Sanches TR; Rodrigues CE; Seguro AC; Andrade L
BMC Nephrol; 2019 Apr; 20(1):140. PubMed ID: 31023272
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of pentoxifylline in advanced chronic kidney disease.
Kao CC; Wu MS
J Formos Med Assoc; 2015 Jan; 114(1):94. PubMed ID: 24974130
[No Abstract] [Full Text] [Related]
20. Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease.
Wu PC; Wu CJ; Lin CJ; Pan CF; Chen CY; Huang TM; Wu CH; Lin SL; Chen YM; Chen L; Wu VC; ;
Clin Pharmacol Ther; 2015 Oct; 98(4):442-9. PubMed ID: 26082272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
